Abstract
Uniformly modified oligodeoxyribonucleotide N3'-->P5' phosphoramidates containing 2'-fluoro-2'-deoxy-pyrimidine nucleosides were synthesized using an efficient interphase amidite transfer reaction. The 3'-amino group of solid phase-supported 2'-fluoro-2'-deoxynucleoside was used as an acceptor and 5'-diisopropylamino phosphoramidite as a donor of a phosphoramidite group in the tetrazole-catalyzed exchange reaction. Subsequent oxidation with aqueous iodine resulted in formation of an internucleoside phosphoramidate diester. The prepared oligo-2'-fluoro-nucleotide N3'-->P5' phosphoramidates form extremely stable duplexes with complementary nucleic acids: relative to isosequential phosphodiester oligomers, the melting temperature Tm of their duplexes with DNA or RNA was increased approximately 4 or 5 degrees C per modification respectively. Moreover, these compounds are highly resistant to enzymatic hydrolysis by snake venom phosphodiesterase and they are 4-5 times more stable in acidic media (pH 2.2-5.3) than the parent oligo-2'-deoxynucleotide N3'-->P5' phosphoramidates. The described properties of the oligo-2'-fluoronucleotide N3'-->P5' phosphoramidates suggest that they may have good potential for diagnostic and antisense therapeutic applications.
Full Text
The Full Text of this article is available as a PDF (109.3 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bielinska A., Shivdasani R. A., Zhang L. Q., Nabel G. J. Regulation of gene expression with double-stranded phosphorothioate oligonucleotides. Science. 1990 Nov 16;250(4983):997–1000. doi: 10.1126/science.2237444. [DOI] [PubMed] [Google Scholar]
- Chen J. K., Schultz R. G., Lloyd D. H., Gryaznov S. M. Synthesis of oligodeoxyribonucleotide N3'-->P5' phosphoramidates. Nucleic Acids Res. 1995 Jul 25;23(14):2661–2668. doi: 10.1093/nar/23.14.2661. [DOI] [PMC free article] [PubMed] [Google Scholar]
- De Mesmaeker A., Altmann K. H., Waldner A., Wendeborn S. Backbone modifications in oligonucleotides and peptide nucleic acid systems. Curr Opin Struct Biol. 1995 Jun;5(3):343–355. doi: 10.1016/0959-440x(95)80096-4. [DOI] [PubMed] [Google Scholar]
- Ding D., Grayaznov S. M., Lloyd D. H., Chandrasekaran S., Yao S., Ratmeyer L., Pan Y., Wilson W. D. An oligodeoxyribonucleotide N3'--> P5' phosphoramidate duplex forms an A-type helix in solution. Nucleic Acids Res. 1996 Jan 15;24(2):354–360. doi: 10.1093/nar/24.2.354. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gryaznov S. M., Letsinger R. L. Synthesis and properties of oligonucleotides containing aminodeoxythymidine units. Nucleic Acids Res. 1992 Jul 11;20(13):3403–3409. doi: 10.1093/nar/20.13.3403. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gryaznov S. M., Letsinger R. L. Template controlled coupling and recombination of oligonucleotide blocks containing thiophosphoryl groups. Nucleic Acids Res. 1993 Mar 25;21(6):1403–1408. doi: 10.1093/nar/21.6.1403. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gryaznov S. M., Lloyd D. H., Chen J. K., Schultz R. G., DeDionisio L. A., Ratmeyer L., Wilson W. D. Oligonucleotide N3'-->P5' phosphoramidates. Proc Natl Acad Sci U S A. 1995 Jun 20;92(13):5798–5802. doi: 10.1073/pnas.92.13.5798. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Guschlbauer W., Jankowski K. Nucleoside conformation is determined by the electronegativity of the sugar substituent. Nucleic Acids Res. 1980 Mar 25;8(6):1421–1433. doi: 10.1093/nar/8.6.1421. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hélène C., Toulmé J. J. Specific regulation of gene expression by antisense, sense and antigene nucleic acids. Biochim Biophys Acta. 1990 Jun 21;1049(2):99–125. doi: 10.1016/0167-4781(90)90031-v. [DOI] [PubMed] [Google Scholar]
- Kawasaki A. M., Casper M. D., Freier S. M., Lesnik E. A., Zounes M. C., Cummins L. L., Gonzalez C., Cook P. D. Uniformly modified 2'-deoxy-2'-fluoro phosphorothioate oligonucleotides as nuclease-resistant antisense compounds with high affinity and specificity for RNA targets. J Med Chem. 1993 Apr 2;36(7):831–841. doi: 10.1021/jm00059a007. [DOI] [PubMed] [Google Scholar]
- Monia B. P., Lesnik E. A., Gonzalez C., Lima W. F., McGee D., Guinosso C. J., Kawasaki A. M., Cook P. D., Freier S. M. Evaluation of 2'-modified oligonucleotides containing 2'-deoxy gaps as antisense inhibitors of gene expression. J Biol Chem. 1993 Jul 5;268(19):14514–14522. [PubMed] [Google Scholar]
- Pieken W. A., Olsen D. B., Benseler F., Aurup H., Eckstein F. Kinetic characterization of ribonuclease-resistant 2'-modified hammerhead ribozymes. Science. 1991 Jul 19;253(5017):314–317. doi: 10.1126/science.1857967. [DOI] [PubMed] [Google Scholar]
- Reichman U., Hollenberg D. H., Chu C. K., Watanabe K. A., Fox J. J. Nucleosides. 98. Direct introduction of an acetamido group into the sugar moiety of nucleoside epoxides. J Org Chem. 1976 May 28;41(11):2042–2043. doi: 10.1021/jo00873a039. [DOI] [PubMed] [Google Scholar]
- Webb T. R., Mitsuya H., Broder S. 1-(2,3-Anhydro-beta-D-lyxofuranosyl)cytosine derivatives as potential inhibitors of the human immunodeficiency virus. J Med Chem. 1988 Jul;31(7):1475–1479. doi: 10.1021/jm00402a038. [DOI] [PubMed] [Google Scholar]
- Williams D. M., Benseler F., Eckstein F. Properties of 2'-fluorothymidine-containing oligonucleotides: interaction with restriction endonuclease EcoRV. Biochemistry. 1991 Apr 23;30(16):4001–4009. doi: 10.1021/bi00230a027. [DOI] [PubMed] [Google Scholar]
- Wyatt J. R., Vickers T. A., Roberson J. L., Buckheit R. W., Jr, Klimkait T., DeBaets E., Davis P. W., Rayner B., Imbach J. L., Ecker D. J. Combinatorially selected guanosine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion. Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1356–1360. doi: 10.1073/pnas.91.4.1356. [DOI] [PMC free article] [PubMed] [Google Scholar]